Brandtree

Who owns Prega News?

Prega News is owned by Mankind Pharma (India, NSE: MANKIND).[1]

This ownership is reported in official statements but has not yet been matched to a regulatory filing.

Evidence: Mankind Pharma Limited Annual Report 2025-26. Last checked .

Key facts

Current owner
Mankind Pharma Limited reported
Owner HQ
🇮🇳 India, New Delhi
Origin
🇮🇳 India
Category
Healthcare & pharma › Devices & animal health › Medical devices
Parent ticker
NSE: MANKIND BSE: 543904
Last verified
· 2 sources

About Prega News

Prega News is Mankind Pharma's home pregnancy detection card, which the company calls India's number one pregnancy test kit. It was launched with Manforce when Mankind entered consumer healthcare between 2007 and 2010, and the 2025-26 annual report puts its sales at ₹248 crore with an 82.6% share of its market. The range has since added Ova News, PregaHope and PregaHappy.

Ownership timeline of Prega News

  1. Current owner Mankind Pharma [1] reported

Where Prega News sits in Mankind Pharma

Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.

Where Prega News sits in Mankind Pharma Tree of 6 brands under Mankind Pharma. Mankind Pharma Prega News Bharat Serums and Vaccines Gas-O-Fast HealthOK Manforce Unwanted

Open the full Mankind Pharma ownership tree →

See the full Mankind Pharma brand portfolio (6) →

Other brands owned by Mankind Pharma

Mankind Pharma controls 6 brands on Brandtree, 3 of them in healthcare & pharma.

Also in healthcare & pharma

All Mankind Pharma brands →

Other brands in devices & animal health, and who owns them

The 12 brands in devices & animal health on Brandtree belong to 4 owners. The largest is Neogen, with 5.

BrandOwnerOwner based in
IDEXX Catalyst One IDEXX 🇺🇸 United States
BotVax B Neogen 🇺🇸 United States
MiniMed Medtronic 🇮🇪 Ireland
IDEXX inVue Dx IDEXX 🇺🇸 United States
IDEXX ProCyte One IDEXX 🇺🇸 United States
IDEXX SediVue Dx IDEXX 🇺🇸 United States
IDEXX SNAP IDEXX 🇺🇸 United States
Ideal Neogen 🇺🇸 United States

Every brand in devices & animal health and its owner →

About the owner: Mankind Pharma

Mankind Pharma is a publicly listed company headquartered in New Delhi, India, founded in 1991. Brandtree records 6 brands under its control, and it is listed as NSE: MANKIND and BSE: 543904.

Mankind Pharma is a New Delhi drug maker incorporated in 1991 that began operating in 1995 and listed on the Indian exchanges in May 2023. Revenue from operations was ₹14,278 crore in 2025-26. Besides prescription medicines it runs a consumer healthcare business through the wholly owned Mankind Consumer Products, which it entered between 2007 and 2010 with Manforce and Prega News. In October 2024 it bought all of Bharat Serums and Vaccines for ₹13,768 crore.

Mankind Pharma: full profile, brands and acquisition history →

🇮🇳 Prega News and other Indian brands

Brandtree records a controlling owner for 279 brands that began in India. 9 of them (3%) are now controlled by a company headquartered in another country; Prega News is not one of them.

All Indian brands and who owns them →

Frequently asked questions

Who is the parent company of Prega News?

The parent company of Prega News is Mankind Pharma, a publicly listed company headquartered in India.

Is Prega News Indian?

Yes. Prega News originated in India and its owner, Mankind Pharma, is also headquartered in India.

Is Prega News still owned by Mankind Pharma?

Yes. As of 21 October 2026, Prega News is still owned by Mankind Pharma. The ownership record was last checked against primary sources on that date.

Sources (2) & corrections

Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.

  1. [1] Mankind Pharma Limited Annual Report 2025-26 — Mankind Pharma Limited, Annual report; retrieved 21 October 2026.
  2. [2] Mankind Pharma — Consumer Healthcare — Mankind Pharma Limited, Official document; retrieved 21 October 2026.

Report a correction Opens a pre-filled GitHub issue. See our corrections policy.